The role of TNF and its receptors in Alzheimer's disease
- PMID: 11754994
- DOI: 10.1016/s0197-4580(01)00291-3
The role of TNF and its receptors in Alzheimer's disease
Abstract
Tumor necrosis factor (TNF) is an important proinflammatory cytokine that is upregulated in Alzheimer disease (AD) patients and involved with AD genes. Several TNF promoter polymorphisms that increase expression are associated with inflammatory and infectious diseases. We previously reported results that detected a AD associated region near the TNF gene. Using family-based association tests we also reported an association between AD and a TNF haplotype in sibling-pair families, and a significant increase in the mean age of onset for a group of African-American AD patients carrying this same haplotype. Previous reports have shown that that the chromosome 1p and chromosome 12p regions are linked to late-onset AD. These two regions harbor TNF receptors (TNFR) 2 and 1, respectively, and binding to them mediates biological effects of TNF. We found a significant asssociation of a TNFR2 exon 6 polymorphism with late-onset AD in families with no individuals possessing the APOE E4E4 genotype under a dominant model. We found no significant association of three polymorphisms in the TNFR1 gene to AD. These results provide further evidence for the involvement of TNF in the pathogenesis of AD.
Similar articles
-
Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative.Am J Med Genet. 2000 Dec 4;96(6):823-30. doi: 10.1002/1096-8628(20001204)96:6<823::aid-ajmg26>3.0.co;2-i. Am J Med Genet. 2000. PMID: 11121190
-
TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes.Hum Immunol. 2003 Feb;64(2):302-9. doi: 10.1016/s0198-8859(02)00799-1. Hum Immunol. 2003. PMID: 12559634
-
Targeting TNF: a therapeutic strategy for Alzheimer's disease.Drug Discov Today. 2014 Nov;19(11):1822-1827. doi: 10.1016/j.drudis.2014.06.029. Epub 2014 Jul 4. Drug Discov Today. 2014. PMID: 24998784 Review.
-
Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease.Arch Neurol. 2006 Aug;63(8):1165-9. doi: 10.1001/archneur.63.8.1165. Arch Neurol. 2006. PMID: 16908746
-
[Biology of tumor necrosis factor type alpha (TNF-alpha)].Pol Merkur Lekarski. 2006 Oct;21(124):358-61. Pol Merkur Lekarski. 2006. PMID: 17205778 Review. Polish.
Cited by
-
Emerging functions and therapeutic targets of IL-38 in central nervous system diseases.CNS Neurosci Ther. 2024 Feb;30(2):e14550. doi: 10.1111/cns.14550. CNS Neurosci Ther. 2024. PMID: 38334236 Free PMC article. Review.
-
Predictors of cognitive decline in older individuals without dementia: An updated meta-analysis.Ann Clin Transl Neurol. 2023 Apr;10(4):497-506. doi: 10.1002/acn3.51740. Epub 2023 Jan 27. Ann Clin Transl Neurol. 2023. PMID: 36705073 Free PMC article. Review.
-
Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury.Neurotherapeutics. 2010 Jan;7(1):22-30. doi: 10.1016/j.nurt.2009.10.016. Neurotherapeutics. 2010. PMID: 20129494 Free PMC article. Review.
-
Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases.Neural Regen Res. 2022 Aug;17(8):1675-1684. doi: 10.4103/1673-5374.332128. Neural Regen Res. 2022. PMID: 35017414 Free PMC article. Review.
-
Present and prospective clinical therapeutic regimens for Alzheimer's disease.Neuropsychiatr Dis Treat. 2008 Aug;4(4):765-77. doi: 10.2147/ndt.s2012. Neuropsychiatr Dis Treat. 2008. PMID: 19043521 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous